Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1033 to 1041 of 1041 entries
Sorted by: Best Match Show Resources per page
The descending pain modulation system predicts short term efficacy of multimodal pain therapy - an observational prospective cohort study.

Postgraduate medicine

Sendel M, Lienau F, Fischer D, Moll J, Koch S, Forstenpointner J, Binder A, Baron R.
PMID: 34895019
Postgrad Med. 2022 Jan 05;1-11. doi: 10.1080/00325481.2021.2017646. Epub 2022 Jan 05.

OBJECTIVES: Treating chronic pain patients with multimodal pain therapy (MMPT) alters perception, awareness, and processing of pain at multiple therapeutic levels. Several clinical observations suggest that the effects of therapy may go beyond the possible sum of each level...

Cite
Sendel M, Lienau F, Fischer D, et al. The descending pain modulation system predicts short term efficacy of multimodal pain therapy - an observational prospective cohort study. Postgrad Med. 2022;1-11doi: 10.1080/00325481.2021.2017646.
Sendel, M., Lienau, F., Fischer, D., Moll, J., Koch, S., Forstenpointner, J., Binder, A., & Baron, R. (2022). The descending pain modulation system predicts short term efficacy of multimodal pain therapy - an observational prospective cohort study. Postgraduate medicine, 1-11. https://doi.org/10.1080/00325481.2021.2017646
Sendel, M, et al. "The descending pain modulation system predicts short term efficacy of multimodal pain therapy - an observational prospective cohort study." Postgraduate medicine vol. (2022): 1-11. doi: https://doi.org/10.1080/00325481.2021.2017646
Sendel M, Lienau F, Fischer D, Moll J, Koch S, Forstenpointner J, Binder A, Baron R. The descending pain modulation system predicts short term efficacy of multimodal pain therapy - an observational prospective cohort study. Postgrad Med. 2022 Jan 05;1-11. doi: 10.1080/00325481.2021.2017646. Epub 2022 Jan 05. PMID: 34895019.
Copy Download .nbib Format: NLM
[Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study. German version].

HNO

Sievert M, Goncalves M, Binder B, Mueller SK, Rupp R, Koch M, Dürr S, Traxdorf M, Hecht M, Iro H, Gostian AO.
PMID: 33837444
HNO. 2022 Jan;70(1):44-50. doi: 10.1007/s00106-021-01029-w. Epub 2021 Apr 09.

BACKGROUND: Recurrent and residual laryngeal cancer after organ-preserving radio- or radiochemotherapy is associated with a poor prognosis. Salvage surgery is the most important therapeutic option in these cases.OBJECTIVE: The study assessed rates of recurrence and residual tumor as well...

Cite
Sievert M, Goncalves M, Binder B, et al. Salvage-Laryngektomie nach primärer Radio- und Radiochemotherapie : Eine retrospektive Fallzusammenfassung. [Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study. German version]. HNO. 2021;70(1):44-50doi: 10.1007/s00106-021-01029-w.
Sievert, M., Goncalves, M., Binder, B., Mueller, S. K., Rupp, R., Koch, M., Dürr, S., Traxdorf, M., Hecht, M., Iro, H., & Gostian, A. O. (2022). Salvage-Laryngektomie nach primärer Radio- und Radiochemotherapie : Eine retrospektive Fallzusammenfassung. [Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study. German version]. HNO, 70(1), 44-50. https://doi.org/10.1007/s00106-021-01029-w
Sievert, Matti, et al. "Salvage-Laryngektomie nach primärer Radio- und Radiochemotherapie : Eine retrospektive Fallzusammenfassung." [Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study. German version]. HNO vol. 70,1 (2022): 44-50. doi: https://doi.org/10.1007/s00106-021-01029-w
Sievert M, Goncalves M, Binder B, Mueller SK, Rupp R, Koch M, Dürr S, Traxdorf M, Hecht M, Iro H, Gostian AO. Salvage-Laryngektomie nach primärer Radio- und Radiochemotherapie : Eine retrospektive Fallzusammenfassung. [Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study. German version]. HNO. 2022 Jan;70(1):44-50. doi: 10.1007/s00106-021-01029-w. Epub 2021 Apr 09. German. PMID: 33837444.
Copy Download .nbib Format: NLM
[Learning from coding data-surgical treatment of benign prostatic syndrome : Big data for BPS].

Der Urologe. Ausg. A

Binder N, Franz J, Sigle A, Gratzke C, Miernik A.
PMID: 34950966
Urologe A. 2021 Dec 23; doi: 10.1007/s00120-021-01739-7. Epub 2021 Dec 23.

Benign prostatic syndrome (BPS) is one of the most common urological diseases. Currently, there are numerous surgical methods to treat BPS. The digitalisation of medicine enables new study approaches in healthcare research using digital data from individual treatment pathways....

Cite
Binder N, Franz J, Sigle A, et al. Lernen aus Kodierungsdaten – chirurgische Behandlung des benignen Prostatasyndroms : Big Data bei N40-Diagnose. [Learning from coding data-surgical treatment of benign prostatic syndrome : Big data for BPS]. Urologe A. 2021;doi: 10.1007/s00120-021-01739-7.
Binder, N., Franz, J., Sigle, A., Gratzke, C., & Miernik, A. (2021). Lernen aus Kodierungsdaten – chirurgische Behandlung des benignen Prostatasyndroms : Big Data bei N40-Diagnose. [Learning from coding data-surgical treatment of benign prostatic syndrome : Big data for BPS]. Der Urologe. Ausg. A, . https://doi.org/10.1007/s00120-021-01739-7
Binder, Nadine, et al. "Lernen aus Kodierungsdaten – chirurgische Behandlung des benignen Prostatasyndroms : Big Data bei N40-Diagnose." [Learning from coding data-surgical treatment of benign prostatic syndrome : Big data for BPS]. Der Urologe. Ausg. A vol. (2021). doi: https://doi.org/10.1007/s00120-021-01739-7
Binder N, Franz J, Sigle A, Gratzke C, Miernik A. Lernen aus Kodierungsdaten – chirurgische Behandlung des benignen Prostatasyndroms : Big Data bei N40-Diagnose. [Learning from coding data-surgical treatment of benign prostatic syndrome : Big data for BPS]. Urologe A. 2021 Dec 23; doi: 10.1007/s00120-021-01739-7. Epub 2021 Dec 23. German. PMID: 34950966.
Copy Download .nbib Format: NLM
Toward Scalable and Unified Example-Based Explanation and Outlier Detection.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society

Chong P, Cheung NM, Elovici Y, Binder A.
PMID: 34793299
IEEE Trans Image Process. 2022;31:525-540. doi: 10.1109/TIP.2021.3127847. Epub 2021 Dec 17.

When neural networks are employed for high-stakes decision-making, it is desirable that they provide explanations for their prediction in order for us to understand the features that have contributed to the decision. At the same time, it is important...

Cite
Chong P, Cheung NM, Elovici Y, et al. Toward Scalable and Unified Example-Based Explanation and Outlier Detection. IEEE Trans Image Process. 2021;31:525-540doi: 10.1109/TIP.2021.3127847.
Chong, P., Cheung, N. M., Elovici, Y., & Binder, A. (2022). Toward Scalable and Unified Example-Based Explanation and Outlier Detection. IEEE transactions on image processing : a publication of the IEEE Signal Processing Society, 31525-540. https://doi.org/10.1109/TIP.2021.3127847
Chong, Penny, et al. "Toward Scalable and Unified Example-Based Explanation and Outlier Detection." IEEE transactions on image processing : a publication of the IEEE Signal Processing Society vol. 31 (2022): 525-540. doi: https://doi.org/10.1109/TIP.2021.3127847
Chong P, Cheung NM, Elovici Y, Binder A. Toward Scalable and Unified Example-Based Explanation and Outlier Detection. IEEE Trans Image Process. 2022;31:525-540. doi: 10.1109/TIP.2021.3127847. Epub 2021 Dec 17. PMID: 34793299.
Copy Download .nbib Format: NLM
Electroconvulsive Therapy in the Epicenter of COVID-19: Experiences and Reflections.

The journal of ECT

Sanghani S, Loewenstein K, Andrus J, Allan S, Mangubat L, Bashkirov I, Glick M, Linder H, Petrides G.
PMID: 34519682
J ECT. 2021 Dec 01;37(4):225-229. doi: 10.1097/YCT.0000000000000796.

No abstract available.

Cite
Sanghani S, Loewenstein K, Andrus J, et al. Electroconvulsive Therapy in the Epicenter of COVID-19: Experiences and Reflections. J ECT. 2021;37(4):225-229doi: 10.1097/YCT.0000000000000796.
Sanghani, S., Loewenstein, K., Andrus, J., Allan, S., Mangubat, L., Bashkirov, I., Glick, M., Linder, H., & Petrides, G. (2021). Electroconvulsive Therapy in the Epicenter of COVID-19: Experiences and Reflections. The journal of ECT, 37(4), 225-229. https://doi.org/10.1097/YCT.0000000000000796
Sanghani, Sohag, et al. "Electroconvulsive Therapy in the Epicenter of COVID-19: Experiences and Reflections." The journal of ECT vol. 37,4 (2021): 225-229. doi: https://doi.org/10.1097/YCT.0000000000000796
Sanghani S, Loewenstein K, Andrus J, Allan S, Mangubat L, Bashkirov I, Glick M, Linder H, Petrides G. Electroconvulsive Therapy in the Epicenter of COVID-19: Experiences and Reflections. J ECT. 2021 Dec 01;37(4):225-229. doi: 10.1097/YCT.0000000000000796. PMID: 34519682.
Copy Download .nbib Format: NLM
The COVID-19 pandemic reduced paediatric emergency department visits but did not significantly increase urgent cases.

Acta paediatrica (Oslo, Norway : 1992)

Beck N, Michel M, Klingkowski U, Binder E, Kapelari K, Maurer M, Lamina C, Müller T, Karall D, Scholl-Bürgi S.
PMID: 34614546
Acta Paediatr. 2022 Jan;111(1):130-132. doi: 10.1111/apa.16138. Epub 2021 Oct 21.

No abstract available.

Cite
Beck N, Michel M, Klingkowski U, et al. The COVID-19 pandemic reduced paediatric emergency department visits but did not significantly increase urgent cases. Acta Paediatr. 2021;111(1):130-132doi: 10.1111/apa.16138.
Beck, N., Michel, M., Klingkowski, U., Binder, E., Kapelari, K., Maurer, M., Lamina, C., Müller, T., Karall, D., & Scholl-Bürgi, S. (2022). The COVID-19 pandemic reduced paediatric emergency department visits but did not significantly increase urgent cases. Acta paediatrica (Oslo, Norway : 1992), 111(1), 130-132. https://doi.org/10.1111/apa.16138
Beck, Nikolas, et al. "The COVID-19 pandemic reduced paediatric emergency department visits but did not significantly increase urgent cases." Acta paediatrica (Oslo, Norway : 1992) vol. 111,1 (2022): 130-132. doi: https://doi.org/10.1111/apa.16138
Beck N, Michel M, Klingkowski U, Binder E, Kapelari K, Maurer M, Lamina C, Müller T, Karall D, Scholl-Bürgi S. The COVID-19 pandemic reduced paediatric emergency department visits but did not significantly increase urgent cases. Acta Paediatr. 2022 Jan;111(1):130-132. doi: 10.1111/apa.16138. Epub 2021 Oct 21. PMID: 34614546; PMCID: PMC8652621.
Copy Download .nbib Format: NLM
Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma.

European journal of gastroenterology & hepatology

Sturm L, Muller L, Schultheiss M, Binder B, Huber JP, Thimme R, Bettinger D.
PMID: 33323760
Eur J Gastroenterol Hepatol. 2020 Dec 14; doi: 10.1097/MEG.0000000000002018. Epub 2020 Dec 14.

BACKGROUND AND AIMS: Several studies have reported associations of proton pump inhibitor (PPI) treatment with the incidence of complications and even increased mortality in patients with liver cirrhosis. Up to now, there are no studies on the impact of...

Cite
Sturm L, Muller L, Schultheiss M, et al. Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2020;doi: 10.1097/MEG.0000000000002018.
Sturm, L., Muller, L., Schultheiss, M., Binder, B., Huber, J. P., Thimme, R., & Bettinger, D. (2020). Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma. European journal of gastroenterology & hepatology, . https://doi.org/10.1097/MEG.0000000000002018
Sturm, Lukas, et al. "Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma." European journal of gastroenterology & hepatology vol. (2020). doi: https://doi.org/10.1097/MEG.0000000000002018
Sturm L, Muller L, Schultheiss M, Binder B, Huber JP, Thimme R, Bettinger D. Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2020 Dec 14; doi: 10.1097/MEG.0000000000002018. Epub 2020 Dec 14. PMID: 33323760.
Copy Download .nbib Format: NLM
ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets.

NPJ vaccines

Marsh GA, McAuley AJ, Au GG, Riddell S, Layton D, Singanallur NB, Layton R, Payne J, Durr PA, Bender H, Barr JA, Bingham J, Boyd V, Brown S, Bruce MP, Burkett K, Eastwood T, Edwards S, Gough T, Halpin K, Harper J, Holmes C, Horman WSJ, van Vuren PJ, Lowther S, Maynard K, McAuley KD, Neave MJ, Poole T, Rootes C, Rowe B, Soldani E, Stevens V, Stewart CR, Suen WW, Tachedjian M, Todd S, Trinidad L, Walter D, Watson N, Drew TW, Gilbert SC, Lambe T, Vasan SS.
PMID: 33972565
NPJ Vaccines. 2021 May 10;6(1):67. doi: 10.1038/s41541-021-00315-6.

Vaccines against SARS-CoV-2 are likely to be critical in the management of the ongoing pandemic. A number of candidates are in Phase III human clinical trials, including ChAdOx1 nCoV-19 (AZD1222), a replication-deficient chimpanzee adenovirus-vectored vaccine candidate. In preclinical trials,...

Cite
Marsh GA, McAuley AJ, Au GG, et al. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets. NPJ Vaccines. 2021;6(1):67doi: 10.1038/s41541-021-00315-6.
Marsh, G. A., McAuley, A. J., Au, G. G., Riddell, S., Layton, D., Singanallur, N. B., Layton, R., Payne, J., Durr, P. A., Bender, H., Barr, J. A., Bingham, J., Boyd, V., Brown, S., Bruce, M. P., Burkett, K., Eastwood, T., Edwards, S., Gough, T., Halpin, K., Harper, J., Holmes, C., Horman, W. S. J., van Vuren, P. J., Lowther, S., Maynard, K., McAuley, K. D., Neave, M. J., Poole, T., Rootes, C., Rowe, B., Soldani, E., Stevens, V., Stewart, C. R., Suen, W. W., Tachedjian, M., Todd, S., Trinidad, L., Walter, D., Watson, N., Drew, T. W., Gilbert, S. C., Lambe, T., & Vasan, S. S. (2021). ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets. NPJ vaccines, 6(1), 67. https://doi.org/10.1038/s41541-021-00315-6
Marsh, Glenn A, et al. "ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets." NPJ vaccines vol. 6,1 (2021): 67. doi: https://doi.org/10.1038/s41541-021-00315-6
Marsh GA, McAuley AJ, Au GG, Riddell S, Layton D, Singanallur NB, Layton R, Payne J, Durr PA, Bender H, Barr JA, Bingham J, Boyd V, Brown S, Bruce MP, Burkett K, Eastwood T, Edwards S, Gough T, Halpin K, Harper J, Holmes C, Horman WSJ, van Vuren PJ, Lowther S, Maynard K, McAuley KD, Neave MJ, Poole T, Rootes C, Rowe B, Soldani E, Stevens V, Stewart CR, Suen WW, Tachedjian M, Todd S, Trinidad L, Walter D, Watson N, Drew TW, Gilbert SC, Lambe T, Vasan SS. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets. NPJ Vaccines. 2021 May 10;6(1):67. doi: 10.1038/s41541-021-00315-6. PMID: 33972565; PMCID: PMC8110954.
Copy Download .nbib Format: NLM
A Randomized Trial of Parenteral Nutrition Using a Mixed Lipid Emulsion Containing Fish Oil in Infants of Extremely Low Birth Weight: Neurodevelopmental Outcome at 12 and 24 Months Corrected Age, A Secondary Outcome Analysis.

The Journal of pediatrics

Thanhaeuser M, Fuiko R, Oberleitner-Leeb C, Brandstaetter S, Binder C, Thajer A, Huber-Dangl M, Haiden N, Pablik E, Berger A, Repa A.
PMID: 32590001
J Pediatr. 2020 Nov;226:142-148.e5. doi: 10.1016/j.jpeds.2020.06.056. Epub 2020 Jun 23.

OBJECTIVE: To examine whether parenteral nutrition using a mixed lipid emulsion containing fish oil improves the neurodevelopmental outcomes of extremely low birth weight infants.STUDY DESIGN: The study is a secondary outcome analysis of a double-blind randomized trial of 230...

Cite
Thanhaeuser M, Fuiko R, Oberleitner-Leeb C, et al. A Randomized Trial of Parenteral Nutrition Using a Mixed Lipid Emulsion Containing Fish Oil in Infants of Extremely Low Birth Weight: Neurodevelopmental Outcome at 12 and 24 Months Corrected Age, A Secondary Outcome Analysis. J Pediatr. 2020;226:142-148.e5doi: 10.1016/j.jpeds.2020.06.056.
Thanhaeuser, M., Fuiko, R., Oberleitner-Leeb, C., Brandstaetter, S., Binder, C., Thajer, A., Huber-Dangl, M., Haiden, N., Pablik, E., Berger, A., & Repa, A. (2020). A Randomized Trial of Parenteral Nutrition Using a Mixed Lipid Emulsion Containing Fish Oil in Infants of Extremely Low Birth Weight: Neurodevelopmental Outcome at 12 and 24 Months Corrected Age, A Secondary Outcome Analysis. The Journal of pediatrics, 226142-148.e5. https://doi.org/10.1016/j.jpeds.2020.06.056
Thanhaeuser, Margarita, et al. "A Randomized Trial of Parenteral Nutrition Using a Mixed Lipid Emulsion Containing Fish Oil in Infants of Extremely Low Birth Weight: Neurodevelopmental Outcome at 12 and 24 Months Corrected Age, A Secondary Outcome Analysis." The Journal of pediatrics vol. 226 (2020): 142-148.e5. doi: https://doi.org/10.1016/j.jpeds.2020.06.056
Thanhaeuser M, Fuiko R, Oberleitner-Leeb C, Brandstaetter S, Binder C, Thajer A, Huber-Dangl M, Haiden N, Pablik E, Berger A, Repa A. A Randomized Trial of Parenteral Nutrition Using a Mixed Lipid Emulsion Containing Fish Oil in Infants of Extremely Low Birth Weight: Neurodevelopmental Outcome at 12 and 24 Months Corrected Age, A Secondary Outcome Analysis. J Pediatr. 2020 Nov;226:142-148.e5. doi: 10.1016/j.jpeds.2020.06.056. Epub 2020 Jun 23. PMID: 32590001.
Copy Download .nbib Format: NLM
Showing 1033 to 1041 of 1041 entries